Literature DB >> 22648150

Prodrugs of theophylline incorporating ethyleneoxy groups in the promoiety: synthesis, characterization, and transdermal delivery.

Susruta Majumdar1, Maren Mueller-Spaeth, Kenneth B Sloan.   

Abstract

Two different types of derivatives of theophylline (Th-H) incorporating ethyleneoxy groups into the promoiety have been synthesized. One is a soft alkyl type where N-methyl-N-methoxyethyleneoxycarbonylaminomethyl chlorides have been used to alkylate Th-H in the 7 position. The other is in an acyl type where methoxyethyleneoxycarbonyl chlorides have been used to acylate Th-H in the 7 position. All of the prodrugs were more soluble in the lipid isopropyl myristate (IPM) than Th-H, and three were more soluble in water (AQ) than Th-H. The most water-soluble prodrug gave the highest maximum delivery of total species containing Th-H through hairless mouse skin from IPM (maximum flux, J(MMIPM))-more than seven times that of Th-H, while the other two gave more than three times that of Th-H. The acyl-type prodrugs delivered only Th-H, while the soft alkyl types delivered 60-70% Th-H plus intact prodrug. The Roberts-Sloan equation was able to predict the best performer for each type with an average of the absolute difference between the experimental log J (MMIPM) and calculated log J (MMIPM) (Δlog J (MMIPM)) of 0.253 log units. The values for the present prodrugs and previously reported prodrugs that had not been previously included in the Roberts-Sloan data base (n = 23) were included in the previous n = 71 data base to give n = 94. New coefficients for the Roberts-Sloan equation have been obtained.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22648150      PMCID: PMC3429689          DOI: 10.1208/s12249-012-9803-6

Source DB:  PubMed          Journal:  AAPS PharmSciTech        ISSN: 1530-9932            Impact factor:   3.246


  17 in total

1.  Correlation of aqueous and lipid solubilities with flux for prodrugs of 5-fluorouracil, theophylline, and 6-mercaptopurine: A Potts-Guy approach.

Authors:  W J Roberts; K B Sloan
Journal:  J Pharm Sci       Date:  1999-05       Impact factor: 3.534

2.  Predicting skin permeability.

Authors:  R O Potts; R H Guy
Journal:  Pharm Res       Date:  1992-05       Impact factor: 4.200

3.  Topical delivery of 5-fluorouracil (5-FU) by 1,3-bisalkylcarbonyl-5-FU prodrugs.

Authors:  Howard D Beall; Kenneth B Sloan
Journal:  Int J Pharm       Date:  2002-01-01       Impact factor: 5.875

4.  Topical delivery of N-alkyl-N-alkyloxycarbonylaminomethyl (NANAOCAM) prodrugs of theophylline (ThH).

Authors:  Susruta Majumdar; K B Sloan
Journal:  Int J Pharm       Date:  2006-09-26       Impact factor: 5.875

5.  Use of solubility parameters of drug and vehicle to predict flux through skin.

Authors:  K B Sloan; S A Koch; K G Siver; F P Flowers
Journal:  J Invest Dermatol       Date:  1986-08       Impact factor: 8.551

6.  7-alkylcarbonyl and 7-alkyloxycarbonyl prodrugs of theophylline.

Authors:  K B Sloan; S A DellaVecchia; J V Estes; W J Roberts
Journal:  Int J Pharm       Date:  2000-09-15       Impact factor: 5.875

7.  Prediction of transdermal flux of prodrugs of 5-fluorouracil, theophylline, and 6-mercaptopurine with a series/parallel model.

Authors:  W J Roberts; K B Sloan
Journal:  J Pharm Sci       Date:  2000-11       Impact factor: 3.534

8.  Topical delivery of 5-fluorouracil and 6-mercaptopurine by their alkylcarbonyloxymethyl prodrugs from water: vehicle effects on design of prodrugs.

Authors:  Kenneth B Sloan; Scott Wasdo; Udo Ezike-Mkparu; Thomas Murray; Donna Nickels; Surjit Singh; Thea Shanks; John Tovar; Karen Ulmer; Robert Waranis
Journal:  Pharm Res       Date:  2003-04       Impact factor: 4.200

9.  Topical delivery of a model phenolic drug: alkyloxycarbonyl prodrugs of acetaminophen.

Authors:  Scott C Wasdo; Kenneth B Sloan
Journal:  Pharm Res       Date:  2004-06       Impact factor: 4.200

Review 10.  Design for optimized topical delivery: Prodrugs and a paradigm change.

Authors:  Kenneth B Sloan; Scott C Wasdo; Jarkko Rautio
Journal:  Pharm Res       Date:  2006-11-16       Impact factor: 4.580

View more
  2 in total

1.  Novel Curcumin Diclofenac Conjugate Enhanced Curcumin Bioavailability and Efficacy in Streptococcal Cell Wall-induced Arthritis.

Authors:  S K Jain; M S Gill; H S Pawar; Sarasija Suresh
Journal:  Indian J Pharm Sci       Date:  2014-09       Impact factor: 0.975

Review 2.  Prodrug strategies for enhancing the percutaneous absorption of drugs.

Authors:  David D N'Da
Journal:  Molecules       Date:  2014-12-12       Impact factor: 4.411

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.